133 related articles for article (PubMed ID: 31855821)
1. Synthesis and biological evaluation of berberine derivatives as a new class of broad-spectrum antiviral agents against Coxsackievirus B.
Zeng QX; Wang HQ; Wei W; Guo TT; Yu L; Wang YX; Li YH; Song DQ
Bioorg Chem; 2020 Jan; 95():103490. PubMed ID: 31855821
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Evolution of Berberine Derivatives as a New Class of Antiviral Agents against Enterovirus 71 through the MEK/ERK Pathway and Autophagy.
Wang YX; Yang L; Wang HQ; Zhao XQ; Liu T; Li YH; Zeng QX; Li YH; Song DQ
Molecules; 2018 Aug; 23(8):. PubMed ID: 30127288
[TBL] [Abstract][Full Text] [Related]
3. Berberine Restricts Coxsackievirus B Type 3 Replication via Inhibition of c-Jun N-Terminal Kinase (JNK) and p38 MAPK Activation In Vitro.
Dai Q; Zhang D; Yu H; Xie W; Xin R; Wang L; Xu X; He X; Xiong J; Sheng H; Zhang L; Zhang K; Hu X
Med Sci Monit; 2017 Mar; 23():1448-1455. PubMed ID: 28341822
[TBL] [Abstract][Full Text] [Related]
4. Novel 12N-substituted matrinanes as potential anti-coxsackievirus agents.
Li YH; Tang S; Li YH; Cheng XY; Zhang X; Wang YX; Su F; Song DQ
Bioorg Med Chem Lett; 2017 Feb; 27(4):829-833. PubMed ID: 28109785
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of halogenated 12N-sulfonyl matrinic butanes as potential anti-coxsackievirus agents.
Cheng XY; Li YH; Tang S; Zhang X; Wang YX; Wang SG; Jiang JD; Li YH; Song DQ
Eur J Med Chem; 2017 Jan; 126():133-142. PubMed ID: 27750147
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-CVB 3 evaluation of substituted 5-nitro-2-phenoxybenzonitriles.
Pürstinger G; De Palma AM; Zimmerhofer G; Huber S; Ladurner S; Neyts J
Bioorg Med Chem Lett; 2008 Sep; 18(18):5123-5. PubMed ID: 18710805
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of N-benzenesulfonyl matrinic acid derivatives as a novel class of coxsackievirus B3 inhibitors.
Wang SG; Kong LY; Li YH; Cheng XY; Su F; Tang S; Bi CW; Jiang JD; Li YH; Song DQ
Bioorg Med Chem Lett; 2015 Sep; 25(17):3690-3. PubMed ID: 26112440
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, structure-activity relationship and in vitro biological evaluation of N-arylethyl isoquinoline derivatives as Coxsackievirus B3 inhibitors.
Wang YX; Li YH; Li YH; Gao RM; Wang HQ; Liu YX; Gao LM; Lu QN; Jiang JD; Song DQ
Bioorg Med Chem Lett; 2011 Oct; 21(19):5787-90. PubMed ID: 21880491
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of berberine.
Warowicka A; Nawrot R; Goździcka-Józefiak A
Arch Virol; 2020 Sep; 165(9):1935-1945. PubMed ID: 32594322
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis and biological evaluation of 12-N-benzenesulfonyl matrinic ether derivatives as anti-coxsackievirus B3 agents].
Cheng XY; Tang S; Kong LY; Li YH; Song DQ
Yao Xue Xue Bao; 2016 Apr; 51(4):606-12. PubMed ID: 29859656
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Identification of Novel Berberine Derivatives as Potent Inhibitors against TNF-α-Induced NF-κB Activation.
Wang YX; Liu L; Zeng QX; Fan TY; Jiang JD; Deng HB; Song DQ
Molecules; 2017 Jul; 22(8):. PubMed ID: 28749438
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship and biological evaluation of berberine derivatives as PCSK9 down-regulating agents.
Fan TY; Yang YX; Zeng QX; Wang XL; Wei W; Guo XX; Zhao LP; Song DQ; Wang YX; Wang L; Hong B
Bioorg Chem; 2021 Aug; 113():104994. PubMed ID: 34052738
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of novel coxsackievirus B3 inhibitors.
Sála M; De Palma AM; Hrebabecký H; Nencka R; Dracínský M; Leyssen P; Neyts J; Holý A
Bioorg Med Chem; 2010 Jun; 18(12):4374-84. PubMed ID: 20576576
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric synthesis of novel triazole derivatives and their in vitro antiviral activity and mechanism of action.
Cao X; Wang W; Wang S; Bao L
Eur J Med Chem; 2017 Oct; 139():718-725. PubMed ID: 28858766
[TBL] [Abstract][Full Text] [Related]
15. New pleconaril and [(biphenyloxy)propyl]isoxazole derivatives with substitutions in the central ring exhibit antiviral activity against pleconaril-resistant coxsackievirus B3.
Schmidtke M; Wutzler P; Zieger R; Riabova OB; Makarov VA
Antiviral Res; 2009 Jan; 81(1):56-63. PubMed ID: 18840470
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of N-substituted sophocarpinic acid derivatives as coxsackievirus B3 inhibitors.
Gao LM; Tang S; Wang YX; Gao RM; Zhang X; Peng ZG; Li JR; Jiang JD; Li YH; Song DQ
ChemMedChem; 2013 Sep; 8(9):1545-53. PubMed ID: 23881611
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Anticancer Activity of 9-O-Pyrazole Alkyl Substituted Berberine Derivatives.
Xiao D; He F; Peng D; Zou M; Peng J; Liu P; Liu Y; Liu Z
Anticancer Agents Med Chem; 2018; 18(11):1639-1648. PubMed ID: 30014806
[TBL] [Abstract][Full Text] [Related]
18. Quinoxaline derivatives as new inhibitors of coxsackievirus B5.
Carta A; Sanna G; Briguglio I; Madeddu S; Vitale G; Piras S; Corona P; Peana AT; Laurini E; Fermeglia M; Pricl S; Serra A; Carta E; Loddo R; Giliberti G
Eur J Med Chem; 2018 Feb; 145():559-569. PubMed ID: 29339251
[TBL] [Abstract][Full Text] [Related]
19. Antiviral Effects of Novel 2-Benzoxyl-Phenylpyridine Derivatives.
Wei Y; Wang H; Xi C; Li N; Li D; Yao C; Sun G; Ge H; Hu K; Zhang Q
Molecules; 2020 Mar; 25(6):. PubMed ID: 32204528
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antiviral activity of 1-(1,3-disubstitutedimidazolidyn-2-ylidene)-3-ethoxycarbonylmethylurea derivatives.
Rządkowska M; Szacoń E; Kaczor AA; Rajtar B; Świątek Ł; Polz-Dacewicz M; Matosiuk D
J Enzyme Inhib Med Chem; 2016; 31(3):361-8. PubMed ID: 25798689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
